Carbohydrate composition as pharmaceutical ingredient and use thereof
US12016925B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 7, 2022 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Feb 7, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0014
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A carbohydrate composition includes fucose, glucuronic acid, galactose, and arabinose. Based on the total weight of the carbohydrate composition, the content of fucose is 45.5% to 76% by weight; the content of glucuronic acid is 11% to 19% by weight; the content of galactose is 4.5% to 14.5% by weight, and the content of arabinose is 5.5% to 18% by weight. A pharmaceutical ingredient including the above-mentioned carbohydrate composition is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.